{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-025395","form_type":"8-K","ticker":null,"cik":"0001805087","company_name":"GELESIS HOLDINGS, INC.","filed_at":"2023-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.681718+00:00","generated_at":"2026-06-14T10:44:13.875635+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Gelesis issues $350K convertible note and 43.1M warrants at $0.0142 to PureTech","bullets":["Issued $350,000 aggregate principal of Convertible Senior Secured Note to PureTech Health LLC (12% annual interest).","Issued warrants to purchase up to 43,133,803 shares of common stock at an exercise price of $0.0142 per share.","Note and warrants sold unregistered under Section 4(a)(2) and Regulation D of the Securities Act.","Limited waiver of Additional Notes Purchase Conditions allowed third closing under existing NPA.","Total outstanding notes from PureTech now $7.35 million following this issuance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-025395","json":"https://secwatch.observer/filing/0000950170-23-025395.json","markdown":"https://secwatch.observer/filing/0000950170-23-025395.md","text":"https://secwatch.observer/filing/0000950170-23-025395.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1805087/000095017023025395/0000950170-23-025395-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1805087/000095017023025395/gls-20230526.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T10:44:13.875635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5b58160cae3add4051353998345eb4f271c4c3a2","claim":"GELESIS HOLDINGS, INC. incurred convertible notes of $350,000 with PureTech Health LLC.","evidence_excerpt":"On May 26, 2023, the Note Parties entered into a Limited Waiver to the NPA (the “Waiver”), pursuant to which the Initial Investor waived the Amended Conditions with respect to the issuance of $350,000 aggregate principal amount of Additional Notes (the “Third Closing Notes”) to the Initial Investor.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1805087/000095017023025395/0000950170-23-025395-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$350,000"},{"label":"Counterparty","value":"PureTech Health LLC"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"c0976a68b862152067313daccb74455a1d3479ca","claim":"GELESIS HOLDINGS, INC. amended Limited Waiver to the NPA with PureTech Health LLC (effective 2023-05-26).","evidence_excerpt":"On May 26, 2023, the Note Parties entered into a Limited Waiver to the NPA (the “Waiver”), pursuant to which the Initial Investor waived the Amended Conditions with respect to the issuance of $350,000 aggregate principal amount of Additional Notes (the “Third Closing Notes”) to the Initial Investor.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1805087/000095017023025395/0000950170-23-025395-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"PureTech Health LLC"},{"label":"Effective","value":"2023-05-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}